Dr. Hanecak is the Senior Director of Licensing in UCI Applied Innovation. Dr. Hanecak is responsible for leading the Invention Transfer Group (ITG). The ITG serves as the focal point for the evaluation, management, and licensing of UCI’s broad intellectual property portfolio (including inventions in the life sciences, biomedical and physical sciences sectors), material transfers, and industry/university interactions involving both research and technology transfer.

Prior to joining UCI in 2002, Dr. Hanecak held research director, project management, and business development positions at Isis Pharmaceuticals, Inc. and Trega Biosciences, Inc. where she managed and expanded multimillion dollar, international research and development collaborations. Drug discovery and development project areas included antisense and small molecule pharmaceutical drug candidates for infectious disease targets, metabolic diseases, inflammatory and immune disorders.

She received her B.A. in Biology from the University of California, San Diego and a Ph.D. in Microbiology from the State University of New York at Stony Brook (now known as Stony Brook University).